The pandemic continues to increase and so far the Covid-19 has caused 4.2 million deaths around the planet. Even in recent weeks there has been a rebound due to the expansion of the Delta Variant. While a favorable aspect is that more and more people have received the vaccine designed against this new disease. There is still a long way to go, but at least it is encouraging news.
Advancement of vaccination in Mexico
In the case of our country, the Ministry of Health (SSa) indicates that from December 23, 2020 until today, 25 million 194 thousand 975 doses of the Pfizer BioNtech vaccine have been accessed; 29 million 392 thousand 400 from AstraZeneca; 20 million from Sinovac; four million 400 thousand from Sputnik V; five million 682 thousand 540 from Cansino and one million 350 thousand from Johnson & Johnson. In the end that gives a total of 86 million 019 thousand 915 doses received packaged and packaged.
Total, 45 million 952 thousand 314 people over 18 years of age have at least one dose of the Covid-19 vaccine. The figure represents an advance of 51 percent and of that amount 25 million 511 thousand 123 people completed their vaccination schedule, which represents 56 percent, and 20 million 441 thousand 191, that is 44 percent, have received the first dose .
Regarding the progress of vaccination against Covid-19 by federal entity, Mexico City is located in first place with 82 percent. They are followed by Baja California, with 79 percent; Baja California Sur, with 76 percent and Chihuahua, with 74 percent. Also also Sinaloa, with 65 percent; Yucatán, with 60 percent; Quintana Roo, with 67 percent, and Aguascalientes, with 57 percent.
But although in broad strokes everything has gone smoothly, there have also been some incidents. The most recent occurred in Nuevo León where a person presented an adverse effect minutes after inoculation, although fortunately it was controlled.
Rare incident but without major consequences
In that sense, Millennium reports that everything took place in the municipality of San Nicolás, attended by a young man between 30 and 39 years old because it is the group that receives immunization in the entity. The application of the first dose caused that while he was in the observation area he presented problems breathing.
The young man was immediately checked by medical and Civil Protection personnel who were at the scene. What was identified is that he was suffering from a cardiac arrhythmia. Therefore, an ambulance that is part of the emergency protocol was automatically used to transfer the young man to a nearby hospital.
After a thorough review, it was verified that the patient had no previous ailments and the problem was controlled. While the report mentions that it was possibly generated as a result of the nerves due to the vaccination.
With the above in mind, the authorities have taken advantage of what happened to reaffirm that the Covid-19 vaccine from any of the pharmaceutical companies should not be feared. All that are available had to pass various tests to prove that they work and do not cause serious adverse effects.